Across TCGA pan-cancer cohorts, CLIC4 Mutation is linked to patient survival in 11 of 34 cancer types, making it a survival-associated CLIC4 data layer compared with 28 for mass-spec protein and 8 for mass-spec protein.
The strongest signal is observed in thymoma (THYM), where higher CLIC4 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated CLIC4 expression acts as an unfavorable survival marker.
THYM, SKCM, and KIRP are the cancer types where CLIC4 Mutation most reproducibly stratifies survival.
Mutation survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.